Indeed, unlike the DA-resistant group, in which a sub-set of patients are characterized by very high prolactin and large tumor size, in the AIPvar group prolactin levels increased little with rising tumor volume, which is unusual for prolactinomas in general (26). This evidence concerns the gene PRL and neoplasm.